GPC3 and hepatocellular carcinoma: Besides, Jiang et al. produced the CRISPR‐edited CAR‐T cells targeting glypican‐3 (GPC3), the protein highly expressed in most liver cancers (Figure 15C).[126] This strategy showed specific killing activity against the GPC3+ HCC cells in vitro and in vivo.